MANGOCEUTICALS INC (MGRX) Stock Price, Quote, News and Overview
NASDAQ:MGRX - Nasdaq - US56270V2051 - Common Stock - Currency: USD
MGRX Quote, Performance and Key Statistics
MANGOCEUTICALS INC
NASDAQ:MGRX (1/24/2025, 8:00:01 PM)
2.99
+0.12 (+4.18%)
The current stock price of MGRX is 2.99 USD. In the past month the price increased by 20.56%. In the past year, price decreased by -42.56%.
MGRX Latest News, Press Releases and Analysis
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Dallas, TX, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing,...
Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing,...
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing,...
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing,...
MGRX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WBA | WALGREENS BOOTS ALLIANCE INC | 4.35 | 10.25B | ||
| GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.37B | ||
| YI | 111 INC | N/A | 452.31M | ||
| CJJD | CHINA JO-JO DRUGSTORES HOLDI | N/A | 11.70M |
Related stock screener links
About MGRX
Company Profile
Mangoceuticals Inc is a US-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The firm has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. The company is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. The company also owns a global patent portfolio of oral solution.
Company Info
MANGOCEUTICALS INC
15110 Dallas Pkwy, Suite 600
Dallas TEXAS US
Employees: 3
Company Website: https://www.mangorx.com/
Investor Relations: https://investors.mangorx.com/
Phone: 18336264679
MGRX FAQ
What is the stock price of MGRX?
The current stock price of MGRX is 2.99 USD.
What is the symbol for MANGOCEUTICALS INC stock?
The exchange symbol of MANGOCEUTICALS INC is MGRX and it is listed on the Nasdaq exchange.
On which exchange is MGRX stock listed?
MGRX stock is listed on the Nasdaq exchange.
Is MGRX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MGRX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MGRX.
Does MGRX stock pay dividends?
MGRX does not pay a dividend.
What is the Price/Earnings (PE) ratio of MGRX?
MGRX does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.88).
What is the Short Interest ratio of MGRX stock?
The outstanding short interest for MGRX is 1.76% of its float.
MGRX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to MGRX. When comparing the yearly performance of all stocks, MGRX is a bad performer in the overall market: 79.46% of all stocks are doing better.
MGRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MGRX. MGRX may be in some trouble as it scores bad on both profitability and health.
MGRX Financial Highlights
Over the last trailing twelve months MGRX reported a non-GAAP Earnings per Share(EPS) of -5.88. The EPS increased by -1021.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -63.05% | ||
| ROE | -69.65% | ||
| Debt/Equity | 0.01 |